Neurotech International Ltd.ASX: NTI

Rett Syndrome Phase I/II trial shows significant benefits

May 6, 2024 at 3:55 AM UTC · Issued by Neurotech International Ltd.

Neurotech International Ltd has released a press release.

View Attachment